Community/Retail

The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia.

Officials with the FDA have approved the supplemental new drug application (sNDA) for BioDelivery Sciences International's buprenorphine and naloxone buccal film (Bunavail).

Researchers from the CDC in Atlanta, Georgia, recently published a study that looked at rotavirus vaccinations’ global impact.

Patients in rural areas who have diabetes often have lower access to care and are more likely to be uninsured, hospitalized, or poor.

CVS Health has lauded findings from new research showing that policies limiting pharmaceutical sales activities at academic medical centers resulted in a modest, but significant change in prescribing behavior.

New research published in the Canadian Medical Association Journal suggests that some commonly prescribed antibiotics may be linked to higher risk of miscarriage in early pregnancy.

It is alarming how much health care fraud within the pharmacy is being prosecuted by the Office of Inspector General.

See what changes are coming to retail pharmacy for Medicare Part D in 2018.

The Hematology Oncology Pharmacy Association (HOPA) is hosting the HOPA Policy Summit on Drug Waste in the Treatment of Cancer with health care professionals and industry members.

The FDA has approved Aurobindo Pharma’s generic version of olmesartan medoxomil and hydrochlorothiazide tablets in 20 mg/12.5 mg, 40 mg/12.5 mg, and 40 mg/25 mg doses.

In 2016, retail pharmacists in the United States dispensed more than 4.4 billion prescriptions from 58,000 retail locations. What happens at change of shift in these pharmacies, and how can we improve?

ACCP has updated its white paper on natural products, and published it in the January issue of the journal Pharmacotherapy.

These are the techniques that got me through pharmacy school, the NAPLEX, and the BCPS exam.

Pillsy, a smart pill bottle and mobile app, is the latest device in the quest to help patients and their loved ones manage medications.

Vitamins and Minerals are natural, but they are not always safe in UNnatural doses from synthetic forms

For two days this week, hundreds of independent community pharmacists came to Capitol Hill in Washington, D.C., to share with Congress real solutions to the problem of skyrocketing prescription drug costs.

The FDA has approved midostaurin (Rydapt, Novartis) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML), in combination with chemotherapy.

Pro-level cyclists, individuals, and groups will be pedaling across the country throughout May in Ride On For Red Nose Day events, raising funds to help end child poverty.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Teaching is a great way to showcase your pharmacy knowledge and expertise.

Patients that express certain human leukocyte variants are at risk for adverse drug events when taking certain medications.

Still struggling with student debt? This is the book for you.

The FDA has expanded the approved use of Stivarga (regorafenib, Bayer HealthCare Pharmaceuticals Inc.) to include the treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.

This article will highlight the available clinical evidence showing the role of biological differences in the effectiveness of smoking cessation pharmacotherapy.

The FDA has approved cerliponase alfa (Brineura, BioMarin Pharmaceutical) to slow loss of walking ability in symptomatic pediatric patients aged 3 years and older with a specific form of Batten disease

This article highlights 5 published case reports that document unusually high doses of medications that are not often seen in clinical practice.

Annual influenza vaccination is prudent for people at high risk from complications and for people who live or work in places where people aggregate.

The playing field for the 2017 Meijer LPGA Classic for Simply Give continues to grow stronger with commitments from its three defending champions.